Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular senescence and cancer.

D Wynford-Thomas1

  • 1Department of Pathology, University of Wales College of Medicine, Cardiff, U.K.

The Journal of Pathology
|May 26, 1999
PubMed
Summary

Cellular aging, or replicative senescence, is driven by telomere shortening and multiple genetic barriers. Overcoming these barriers is crucial for cancer development and presents therapeutic targets like telomerase inhibition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: p53 promotes adenoviral replication and increases late viral gene expression.

Oncogene·2026
Same author

Human thyroid epithelial cells.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Transfection and transformation of human thyroid epithelial cells.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

British journal of cancer·2006
Same author

p53 promotes adenoviral replication and increases late viral gene expression.

Oncogene·2005
Same author

Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context.

Endocrinology·2003

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Genetics

Background:

  • Normal mammalian cell proliferation is limited by intrinsic controls, leading to replicative senescence.
  • Telomere erosion with each DNA replication round acts as a key cellular clock, triggering senescence.
  • Tumor suppressor genes (TSGs) like p53 and p16INK4a, and cell-cycle inhibitors like p21WAF1, are involved in senescence pathways.

Purpose of the Study:

  • To elucidate the mechanisms underlying cellular proliferative lifespan limitation.
  • To explain the accumulation of genetic abnormalities in cancer development.
  • To explore telomere maintenance and its role in cancer immortalization and therapeutic strategies.

Main Methods:

  • The study is primarily theoretical, synthesizing existing knowledge on cellular senescence and cancer genetics.
  • It analyzes the roles of telomere dynamics, tumor suppressor genes, and cell-cycle inhibitors.
  • It discusses the concept of proliferative lifespan barriers (PLBs) and their genetic underpinnings.

Main Results:

  • Replicative senescence is a multi-step process involving multiple genetic barriers (PLBs) that must be overcome for tumor development.
  • Telomere erosion is a critical factor, and its halt via telomerase is essential for cancer cell immortalization.
  • The diversity of PLBs contributes to the varying genetic profiles of different cancers.

Conclusions:

  • Cancer development requires overcoming multiple genetic barriers, explaining the complexity of cancer genomes.
  • Telomere maintenance, often through telomerase activation, is a hallmark of cancer immortality.
  • Targeting telomerase offers a promising strategy for selective cancer cell killing.

Related Experiment Videos